Cita APA

Wong, Y., Manola, J., Hudes, G. R., Roth, B. J., Moul, J. W., Barsevick, A. M., . . . Wilding, G. (2017). Phase II Study of Weekly Paclitaxel by 1-HR Infusion plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: A trial of the ECOG-ACRIN Cancer Research Group (E1898). Clin Genitourin Cancer.

Chicago Style Citation

Wong, Yu-Ning, et al. "Phase II Study of Weekly Paclitaxel By 1-HR Infusion Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E1898)." Clin Genitourin Cancer 2017.

Cita MLA

Wong, Yu-Ning, et al. "Phase II Study of Weekly Paclitaxel By 1-HR Infusion Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E1898)." Clin Genitourin Cancer 2017.